Clinical Trial: A Trial of ONO-2808 in Participants With the Parkinsonian Subtype of Multiple System Atrophy (MSA-P)

U.S., Sept. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07825402) titled 'A Trial of ONO-2808 in Participants With the Parkinsonian Subtype of Multiple System Atrophy (MSA-P)' on Sept. 13.

Brief Summary: The main goal of this clinical trial is to learn if ONO-2808 works to treat adults with the Parkinsonian subtype of Multiple System Atrophy (MSA-P). Researchers will compare ONO-2808 to a placebo (a look-alike substance that contains no drug) to see if ONO-2808 works to treat MSA-P.

Participants will:

* Take ONO-2808 or placebo orally for up to 48 weeks

* Make visits to the clinic for checkups and tests

* Answer questions about their health throughout the trial.

Study Start Date: Jan., 2027

Study T...